Are you thinking about adding the element of reconstructive microsurgery to your private practice? Where do you begin partnering with a local hospital? How do you navigate reimbursements? What staff is needed in the operating room and post-op? How do you prepare for complications that may arise? These questions and more are answered. We cover the basics from what additional steps should be taken at patient check-in to ensure timely reimbursement, to the free flap microsurgery codes you should know, the additional microsurgery equipment, supplies, and instruments needed in the operating room and what to look for during postoperative flap monitoring.
Learning Objectives
Upon completion of this course, you should be able to:
- Identify major components you will need to navigate when adding reconstructive microsurgery to your private practice.
- Develop a process that is adaptable, efficient, and focused on improving outcomes.
Faculty
Content for this course was derived from the 2020 PSTM session The Business of Microsurgery in Private Practice. The panel consisted of Dr. Maurice Nahabedian, Dr. Andy Guth, Dr. Anureet Bajaj, Dr. Minas Chrysopoulo, Dr. Pankaj Tiwari. This course has been reviewed by Dr. Maurice Nahabedian, Dr. Edward Chang, and Dr. Nicholas Panetta.
AMA PRA Category 1 CreditTM: 1.0
Patient Safety Credit: 0.0
Media: eLearning
Release Date: 3/1/2021
Expiration Date: 2/28/2024
Estimated time to complete this course: 1 hour
Directly provided by the American Society of Plastic Surgeons® (ASPS®)
Accreditation Statement The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.
Intended Audience
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.
Disclosures
Maurice Nahbedian MD Commercial Interest: Allergan $50,001-$100,000
Minas T. Chrysopoulo MD Commercial Interest: Allergan $100-$1,000; Business Concerns: CEO Toliman Health, LLC; Investments: Toliman Health, LLC $200,001-$500,000; Commpensation: Allergan $100-$1,000
All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.